mefloquine has been researched along with Day Blindness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikoma, Y; Kakita, A; Kitagawa, J; Mochizuki, K; Nakamichi, K; Ohe, N; Otsuki, M; Ozawa, K; Saijo, M; Shimohata, T; Takekoshi, A; Takeshima, A; Yoshikura, N | 1 |
| Adabayeri, VM; Adjei, GO; Annobil, SH | 1 |
| Bygbjerg, IC; Rønn, AM | 1 |
3 other study(ies) available for mefloquine and Day Blindness
| Article | Year |
|---|---|
[A Patient with Progressive Multifocal Leukoencephalopathy Who Developed Bálint Syndrome Improved by Combination Therapy Using Mefloquine and Mirtazapine].
Topics: Apraxias; Brain; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Middle Aged; Mirtazapine; Vision Disorders | 2019 |
Reversible binocular visual loss in temporal association with artesunate-amodiaquine treatment in a child on mefloquine chemoprophylaxis.
Topics: Amodiaquine; Anti-Inflammatory Agents; Antimalarials; Artemisinins; Chemoprevention; Child; Dexamethasone; Drug Combinations; Female; Humans; Malaria; Mefloquine; Time Factors; Vision Disorders; Visual Acuity | 2012 |
[Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
Topics: Adult; Antimalarials; Anxiety Disorders; Brain Diseases; Female; Headache; Humans; Mefloquine; Mental Disorders; Neurologic Examination; Time Factors; Vision Disorders | 1999 |